Lexaria Bioscience
LEXX
LEXX
27 hedge funds and large institutions have $3.25M invested in Lexaria Bioscience in 2024 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
43% less capital invested
Capital invested by funds: $5.72M → $3.25M (-$2.47M)
Holders
27
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$109K | |
| 2 | +$47.1K | |
| 3 | +$42.3K | |
| 4 |
HighTower Advisors
Chicago,
Illinois
|
+$40K |
| 5 |
HF
HRT Financial
New York
|
+$31K |
Top Sellers
| 1 | -$2.84M | |
| 2 | -$115K | |
| 3 | -$63.4K | |
| 4 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
-$11.9K |
| 5 |
1832 Asset Management
Toronto,
Ontario, Canada
|
-$7.47K |